Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed

SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 -- DiaSorin and Cytek Biosciences, Inc. today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has completed the... | February 28, 2023

Related Keywords

China ,Fremont ,California ,United States ,Italy ,Saluggia ,Piemonte ,Italian ,Eugenia Ragazzo ,Stephanie Olsen ,Cytek Bioscience ,Cytek Biosciences ,Linkedin ,Twitter ,Italian Stock Exchange ,Lages Associates ,Nasdaq ,Exchange Commission ,Youtube ,Cytek Biosciences Inc ,European Union ,Securities Exchange ,Luminex Corporation ,Flow Cytometry ,Capital Market Day ,Vitro Diagnostic ,Life Science ,Full Spectrum Profiling ,Northern Lights ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Cytek Bioscience Quarterly Report ,Annual Report ,Nc Stock Exchange ,News ,Information ,Press Release ,023 ,Diasorin ,End ,Crytek ,Oday ,Nnounced ,Hat ,Luminex ,Holly ,Wned ,Ubsidiary ,F ,Gas ,Ompleted Ctkb Us23285d1090 ,